Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Milano, Italy.
Humanitas Clinical Research Center IRCCS, Rozzano, Milano, Italy.
Dev Cell. 2020 Nov 23;55(4):398-412.e7. doi: 10.1016/j.devcel.2020.09.011. Epub 2020 Sep 29.
Many tumors of endodermal origin are composed of highly secretory cancer cells that must adapt endoplasmic reticulum (ER) activity to enable proper folding of secreted proteins and prevent ER stress. We found that pancreatic ductal adenocarcinomas (PDACs) overexpress the myelin regulatory factor (MYRF), an ER membrane-associated transcription factor (TF) released by self-cleavage. MYRF was expressed in the well-differentiated secretory cancer cells, but not in the poorly differentiated quasi-mesenchymal cells that coexist in the same tumor. MYRF expression was controlled by the epithelial identity TF HNF1B, and it acted to fine-tune the expression of genes encoding highly glycosylated, cysteine-rich secretory proteins, thus preventing ER overload. MYRF-deficient PDAC cells showed signs of ER stress, impaired proliferation, and an inability to form spheroids in vitro, while in vivo they generated highly secretory but poorly proliferating and hypocellular tumors. These data indicate a role of MYRF in the control of ER homeostasis in highly secretory PDAC cells.
许多内胚层来源的肿瘤由高度分泌性的癌细胞组成,这些细胞必须适应内质网 (ER) 活性,以实现分泌蛋白的正确折叠,并防止 ER 应激。我们发现胰腺导管腺癌 (PDAC) 过度表达髓鞘调节因子 (MYRF),这是一种由自身切割释放的内质网膜相关转录因子 (TF)。MYRF 在分化良好的分泌性癌细胞中表达,但不在同一肿瘤中共存的分化不良的类间充质细胞中表达。MYRF 的表达受上皮身份 TF HNF1B 控制,它可精细调节编码高度糖基化、富含半胱氨酸的分泌蛋白的基因表达,从而防止 ER 过载。缺乏 MYRF 的 PDAC 细胞表现出 ER 应激的迹象,增殖受损,并且无法在体外形成球体,而在体内,它们生成高度分泌但增殖能力差且细胞数量少的肿瘤。这些数据表明 MYRF 在高度分泌性 PDAC 细胞的 ER 稳态控制中发挥作用。